Company profile: Tempus
1.1 - Company Overview
Company description
- Provider of AI-driven precision medicine solutions that analyze clinical and molecular data to personalize care, including comprehensive genomic profiling (DNA/RNA sequencing) for cancer, clinical trial matching, AI-enabled algorithmic tests (HRD, TO, DPYD), digital pathology & AI tools, the Tempus One clinical assistant, and EHR integration for seamless access to genomic insights and treatment options.
Products and services
- Genomic Profiling: Delivers DNA/RNA-based comprehensive sequencing to analyze and interpret clinical and molecular data, producing patient-specific insights guiding cancer treatment options
- AI-Enabled Algorithmic Tests: Architects AI-enabled predictive assays that forecast cancer treatment responses and pinpoint biomarkers, including HRD, TO, and DPYD tests
- Clinical Trial Matching: Supplies data-driven matching that aligns patients to clinical trials using their molecular and clinical data, facilitating faster trial enrollment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tempus
ZYTO
HQ: Ireland
Website
- Description: Provider of software and integrated hardware products that use ZYTO scan technology to provide insight into personal health and wellness decisions. Offerings include the ZYTO Hand Cradle for galvanic skin response; ZYTO Pro, Compass, and Balance for biomarker analysis; ZYTO Link for remote scanning and client management; and ZYTO EVOX for emotional wellness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZYTO company profile →
Availity
HQ: United States
Website
- Description: Provider of free access to real-time information and instant responses for healthcare professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Availity company profile →
Lievestro
HQ: The Netherlands
Website
- Description: Provider of capacity planning software for hospitals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lievestro company profile →
Lumeon
HQ: United Kingdom
Website
- Description: Provider of digital health Care Pathway Management solutions for the healthcare industry, spanning scheduling, revenue management, clinical reporting, and aftercare, by looking across the end-to-end care pathway to address the system behind healthcare transformation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lumeon company profile →
Medified
HQ: Finland
Website
- Description: Provider of cloud-based SaaS for healthcare providers delivering digital mental health treatment monitoring software that enables data-driven, AI-supported clinical insights and personalized treatment paths. Offers a CE-certified medical device with end-to-end encrypted data flow between professionals and patients, and a blended treatment model combining psychologist video calls with self-help iCBT via app.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medified company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tempus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tempus
2.2 - Growth funds investing in similar companies to Tempus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tempus
4.2 - Public trading comparable groups for Tempus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →